Drug intelligence / Profile preview

99mTc-HYNIC-PEG liposome

Development stage
Unknown
Modality
Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
Administration
Intravenous
01

Overview

99mTc-HYNIC-PEG liposome is a **radiolabeled PEGylated liposome** in which the liposome membrane incorporates a hydrazino-nicotinyl (HYNIC) derivative as a chelator, enabling rapid and stable labeling with the gamma-emitting radionuclide technetium-99m (99mTc)[1][3]. The addition of a polyethylene glycol (PEG) layer increases circulation time and reduces uptake by the reticuloendothelial system. This compound is primarily developed as a **radiopharmaceutical for SPECT imaging**, particularly to track the in vivo distribution and localization of liposomal drug formulations and as an infection imaging agent. The 99mTc-HYNIC labeling method offers higher efficiency and stability than prior methods, facilitating clinical workflow and enhancing image quality[1][3]. PEGylated formulations exhibit improved tumor or infection site localization via the enhanced permeability and retention effect, making them valuable for noninvasive monitoring of drug delivery and disease localization.

Other names
technetium-99m HYNIC PEGylated liposometechnetium99m HYNIC PEGylated liposometechnetium 99m HYNIC PEGylated liposomeTc-99m-HYNIC-PEG-liposomeTc99m-HYNIC-PEG-liposomeTc 99m-HYNIC-PEG-liposome

Beyond the preview

Go deeper on 99mTc-HYNIC-PEG liposome.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 99mTc-HYNIC-PEG liposome.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call